Histamine

Flushing, hives, a pounding heart, and abdominal cramps can have several causes. Free urinary histamine has been studied as a clue to histamine release, but its diagnostic role remains exploratory. It cannot establish that allergies, mast cell disease, or reactions to food are causing your symptoms.

This test measures unchanged histamine in urine using LC-MS. The method separates chemicals in the sample and identifies histamine through its molecular properties. A well-validated assay can measure the molecule accurately, but that doesn't establish where it came from or which condition caused the result. Disease-specific decision limits and treatment targets for this test haven't been validated.

Where Urinary Histamine Comes From

Your body makes histamine from a building block of protein called histidine. Mast cells and basophils are immune cells that store histamine and release it during allergic and other immune responses. Histamine also helps regulate stomach acid production and signaling between nerve cells.

Enzymes break down released histamine quickly. Diamine oxidase (DAO) helps break it down outside cells, including in the intestine. A separate route inside cells produces N-methylhistamine, which is also called 1-methylhistamine. Further processing produces 1-methyl-4-imidazoleacetic acid (MIMA).

Most released histamine is broken down before it leaves your body. Free urinary histamine captures the smaller amount excreted unchanged. N-methylhistamine and MIMA are separate measurements, and findings about those breakdown products cannot be treated as findings about free histamine.

Mastocytosis and Mast Cell Activation

In systemic mastocytosis, abnormal mast cells accumulate in the bone marrow and sometimes other organs. Urinary histamine breakdown products have been associated with the extent of mast cell accumulation. Free urinary histamine has been less reliable for this purpose.

In a 1983 study of eight adults with mastocytosis, only three had raised urinary histamine, while all eight had raised histamine breakdown products. This was a small study using historical assays, not a validation of the current LC-MS test. Its finding supports the distinction between the molecules; it doesn't provide a dependable sensitivity estimate for your assay.

Mast cell activation syndrome involves recurrent episodes affecting more than one body system, objective evidence of mast cell activation, and improvement with treatment directed at mast cell signals. Symptoms alone don't establish it. Blood tryptase is the best-established laboratory marker for an acute episode, interpreted against your own baseline. A normal baseline tryptase does not exclude episodic activation.

Hereditary alpha tryptasemia is an inherited cause of a higher baseline tryptase. A 2025 study of people evaluated for mast cell disorders explored whether a ratio of baseline blood tryptase to urinary N-methylhistamine could help flag this trait. These results concern a ratio using a different urine analyte. They don't describe this test's accuracy, and confirmation of the inherited trait requires genetic testing.

Histamine Intolerance and Food Reactions

Histamine intolerance is a proposed explanation for symptoms after histamine-containing foods. Reduced breakdown of dietary histamine is one suggested mechanism, but symptoms do not establish that you have low intestinal DAO activity. There is no validated urine test that confirms this diagnosis.

A pilot study of 87 adults found lower urinary N-methylhistamine with suspected histamine intolerance, while free histamine did not differ significantly from controls. Neither urine marker distinguished the low-DAO subgroup. It used fluorescence detection, so its measurements cannot be assumed interchangeable with this LC-MS assay.

Bladder Pain and Interstitial Cystitis

Bladder pain syndrome is also called interstitial cystitis. It involves persistent bladder-related pain with urinary symptoms after other causes have been excluded. Some small studies found slightly higher urinary histamine and larger differences in methylhistamine. Other experiments measured changes after the bladder was stretched during a procedure. These older studies did not validate this LC-MS assay. Their findings concern selected groups and, in some cases, deliberately provoked release; they don't establish the accuracy of an ordinary urine collection.

A separate study of painful bladder disease found roughly twice as much urinary MIMA in people with increased mast cells in the bladder muscle. It measured a different molecule in 24-hour urine using a different laboratory method. Free urinary histamine has not been validated for diagnosing bladder pain syndrome or deciding whether you need a bladder biopsy.

Other Research Findings

In a study comparing irritable bowel syndrome with ulcerative colitis in remission and healthy controls, urinary histamine was associated with IBS symptom severity. The researchers used a research profiling protocol involving several mass-spectrometry methods. This association has not established a diagnostic or treatment-monitoring role for this particular assay.

Raised urinary histamine has also been reported in some people with familial Mediterranean fever. Older studies of chronic myeloid leukemia found increased excretion of histamine breakdown products. During experimental influenza infection, a combined measure of urinary histamine and its breakdown products rose. These findings help explain why histamine-related urine measurements are not specific to allergy or mast cell disease; the combined and breakdown-product measurements are different from this test.

Older studies found that urinary histamine could remain unremarkable in severe asthma and during hereditary angioedema attacks. The asthma study used an enzymatic isotope assay rather than LC-MS. These observations do not make a normal urine result a reliable way to exclude a mast cell disorder or explain recurrent swelling.

When Results Can Be Misleading

• Bacterial contamination or urinary infection: bacteria can produce histamine in urine, so a raised result may have a source other than your immune cells.
• Storage and transport: free histamine can change during storage. A published LC-MS/MS validation found better stability with frozen storage than prolonged refrigeration, and some samples changed after freezing and thawing. The collection kit's handling instructions matter.
• Time of day: a small study using an antibody-based assay found within-day variation in urinary histamine. It does not establish a universal daily pattern or a correction that can be applied to this LC-MS result.
• Diet and recent activity: dietary histamine can affect urine measurements. Exercise studies require a separate distinction: a 2026 study found increased urinary histamine breakdown products after exercise, while free histamine excretion did not change significantly.
• Urine concentration: results expressed relative to creatinine depend partly on creatinine excretion. Creatinine correction reduces the effect of urine dilution but does not make different collection protocols interchangeable.
• LC-MS limitations: other substances in urine can weaken or strengthen the instrument's signal, and sample preparation and calibration can affect the number. Laboratories need to validate and control these effects. LC-MS also cannot distinguish histamine made by bacteria from the same molecule released by your cells.

An unexpected result needs its collection history, symptoms, and companion findings. There is no validated percentage change in free urinary histamine that proves recovery, and repeated measurements do not resolve the test's limited ability to identify a cause.